Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 11, Pages 3241-3250
Publisher
Informa UK Limited
Online
2014-07-09
DOI
10.4161/hv.29275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
- (2014) Li-Sheng Chang et al. Molecular Cancer
- Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors
- (2013) Sofia Eberstål et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth
- (2012) Aline Bolpetti et al. BMC IMMUNOLOGY
- A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors
- (2012) B G Wieking et al. CANCER GENE THERAPY
- Macrophages in Tumor Microenvironments and the Progression of Tumors
- (2012) Ning-Bo Hao et al. Clinical & Developmental Immunology
- Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
- (2012) Y. Dang et al. CLINICAL CANCER RESEARCH
- The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology
- (2012) Weixiao Sha et al. IMMUNOBIOLOGY
- Recombinant Lipidated HPV E7 Induces a Th-1-Biased Immune Response and Protective Immunity against Cervical Cancer in a Mouse Model
- (2012) Chiung-Yi Huang et al. PLoS One
- Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery
- (2012) J. Predina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activity
- (2012) Amanda M. Guth et al. OncoImmunology
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Advances in human papilloma virus vaccines: a patent review
- (2011) Hee-Jeong Cho et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
- (2011) Takami Sato et al. IMMUNOLOGIC RESEARCH
- A Modular Approach to Assembly of Totally Synthetic Self-adjuvanting Lipopeptide-based Vaccines Allows Conformational Epitope Building
- (2011) Weiguang Zeng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Presentation of lipopeptide by dendritic cells induces anti-tumor responses via an endocytosis-independent pathway in vivo
- (2011) Ying-Chyi Song et al. JOURNAL OF LEUKOCYTE BIOLOGY
- T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer
- (2011) Paul K.S. Chan et al. JOURNAL OF MEDICAL VIROLOGY
- Identification and manipulation of tumor associated macrophages in human cancers
- (2011) Moniek Heusinkveld et al. Journal of Translational Medicine
- New Approaches to Immunotherapy for HPV Associated Cancers
- (2011) Anne-Sophie Bergot et al. Cancers
- Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development
- (2011) E. Guzmán-Olea et al. Journal of Oncology
- Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization
- (2010) Hsin-Wei Chen et al. CANCER BIOLOGY & THERAPY
- T-Cell Response to Human Papillomavirus Type 58 L1, E6, and E7 Peptides in Women with Cleared Infection, Cervical Intraepithelial Neoplasia, or Invasive Cancer
- (2010) P. K. S. Chan et al. Clinical and Vaccine Immunology
- The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens
- (2010) Chittappen K. Prajeeth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Structure−Activity Relationships in Toll-like Receptor-2 Agonistic Diacylthioglycerol Lipopeptides
- (2010) Wenyan Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
- (2010) Masahiro Azuma et al. PLoS One
- HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses
- (2009) A. P. Lepique et al. CLINICAL CANCER RESEARCH
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design
- (2009) Hsin-Wei Chen et al. VACCINE
- Therapeutic human papillomavirus vaccines: current clinical trials and future directions
- (2008) Chien-Fu Hung et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
- (2008) Brendon Y. Chua et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More